Mounjaro®
Starting from £179.99/mo
Start journey Learn moreWegovy's 0.50 mg dose sits in the early titration schedule, and understanding what it costs in the UK starts with one honest fact: there is no single fixed price for private semaglutide treatment. What you pay depends on the provider, what they include, and whether that figure covers the full clinical picture or just the pen. Wegovy is a prescription-only medicine, meaning a prescriber must assess your suitability before any treatment can be dispensed, and that clinical assessment should be part of what you're paying for, not a hidden extra. Private providers set their own prices; reported figures for semaglutide treatment in the UK have typically ranged from around £149 to over £300 per month depending on dose and service, as covered in detail on our Wegovy UK price guide.
At your door the next working day.
Free, tracked, plain packaging.
BMI isn't the whole story, but it's where clinicians start. Check yours in ten seconds — nothing is stored, nothing is shared.
Ten seconds. Private — nothing is stored or shared.
Your result updates live in the card alongside.
Your result
Your BMI is
—
which is in the healthy weight range
Start journeyBMI doesn't determine eligibility — only a clinician can assess whether treatment is right for you.
The problem
The nume way
clinician review. Free next working day delivery.
How it works
Tell us about your health, history and goals. Free, online, and confidential — no commitment, no waiting room.
Our team reviews your health the same day — never an algorithm, and approves your treatment there and then if eligible.
Order by 12pm, dispatched same day, delivered free the next working day — the nume Promise.
The 0.50 mg dose of Wegovy is a step in a licensed titration schedule rather than a maintenance dose. NICE's appraisal of semaglutide for weight management (TA875) acknowledges the escalating schedule as integral to how the medicine works, with 2.4 mg as the target maintenance level for most people. The STEP 1 trial, published in the New England Journal of Medicine, showed an average weight reduction of around 15% over 68 weeks at the 2.4 mg maintenance dose. The 0.50 mg stage is earlier in that journey: the body is adjusting, tolerability is the priority, and clinical results build across the full titration period rather than at any single dose level.
This matters for pricing because most private providers price treatment per pen, per month, or as a tiered monthly fee that changes with each dose increase. A quote for 0.50 mg is not, in practice, a quote for the full course. If you want to understand what you are likely to pay at this specific point in the schedule, our page covering what Wegovy 0.5 costs and how that figure fits into the broader treatment journey is a useful place to start. The Wegovy overview page explains how the full dose schedule works in plain terms, which is a useful starting point before comparing provider costs.
NICE's recommendation also stipulates that semaglutide should be used within a specialist weight management service for a maximum of two years, and that treatment should be reviewed if less than 5% weight loss is achieved after six months on the maintenance dose. These clinical parameters shape what responsible private provision looks like, regardless of price.
A figure quoted for a single pen does not always reflect what the full private treatment experience costs. Across the UK private market, some providers charge separately for the initial consultation, the written prescription, delivery, follow-up reviews, or dose-change assessments. Taken individually each fee may appear modest, but they accumulate quickly across a multi-month course.
It is also worth noting that clinical oversight is not uniform. Some online services rely on automated questionnaires with minimal human review. Others, particularly those competing primarily on price, may not include structured aftercare or a named prescriber available to discuss your progress. For a medicine like Wegovy, where side effects are predominantly gastrointestinal and often front-loaded in the titration period, access to clinical support matters in a practical sense, not just a regulatory one.
Our detailed breakdown of 0.5 mg semaglutide costs in the UK looks specifically at this dose level across the market. The question of what a price actually covers is addressed there more fully, and it is the right question to ask before committing to any provider. For a closer look at how the 0.5 mg dose is priced across providers, our page on the Wegovy 0.5mg price and what different services include for that figure sets out the detail worth checking. Delivery timing is worth checking too: some providers dispatch weekly, others on a fixed date regardless of when you order, which can matter if your prescription falls across a bank holiday or a period you are travelling.
nume charges one transparent price that covers the consultation, the prescription, the medicine, and delivery. There are no separate administration fees, no charges for clinical follow-up, and no subscription that auto-renews. Every repeat order goes back to a GPhC-registered Independent Prescriber for review before anything is dispatched.
We are not the least expensive option in the UK market. That is a deliberate choice, not an oversight. Competing on price for a prescription medicine means trimming the parts of the service that protect patients, and we will not do that. If you order before 12pm on a weekday, Monday through Friday, your treatment is dispatched the same day once clinically approved and arrives the next working day via DPD in plain, unbranded packaging. For people who order mid-week ahead of a long weekend, that timing is worth confirming with our team via the contact page.
Details about what treatment currently costs at each stage are on our treatment page. We do not publish per-pen prices in body copy, because the right figure depends on your individual clinical picture and the dose your prescriber confirms is appropriate. What we can say plainly is that everything is included in one number, and that number does not change between checkout and delivery.
For a prescription-only medicine, price is an incomplete measure of value. Wegovy must be sourced through the licensed UK supply chain from an MHRA-regulated pharmacy. The MHRA has issued repeated warnings about counterfeit semaglutide products sold online, often at prices below legitimate market rates. Sellers offering these medicines without a clinical assessment or a valid UK prescription are operating outside the law, and the product they supply has no guaranteed composition or sterility.
Verifying a pharmacy on the GPhC register takes under a minute and confirms whether a service is actually regulated. You can verify nume directly: our GPhC premises registration is 9012878. It is listed at the register and is the clearest signal that the supply chain behind your treatment is legitimate.
Semaglutide that costs significantly less than the market range is not a bargain. It is a question mark over what you are actually receiving. For more background on what to check before ordering from any online pharmacy, the FAQs page covers the key steps. And if you are comparing Wegovy with the other licensed weekly injection, the 1 mg dose cost context and the broader weight-loss treatment overview may help clarify which option fits your situation.
The people
Superintendent Pharmacist (GPhC No. 2217101)
Accountable for the safe running of our registered pharmacy, from every dispensing check to every dispatch.
Clinical Lead (GPhC No. 2231744)
Sets our clinical standards and checks everything we publish against current MHRA guidance.
Independent Prescriber (GPhC No. 2084501)
Personally reviews consultations and assesses whether treatment is clinically appropriate, and leads dose adjustments and follow-up checks.
Independent Prescriber (GPhC No. 2083426)
Personally reviews consultations and assesses whether treatment is clinically appropriate, and leads dose adjustments and follow-up checks.